Ann: Appendix 4C and Quarterly Update, page-16

Post-trial, some veterinarians and the respective pet owners have elected to continue MPL treatment and,
sometimes, in combination with prednisolone. The combination of MPL with prednisolone has provided average
extension of survival to these pet dogs of 16-24 weeks, more than double the life expectancy than standard of
care (palliative steroid therapy) that typically provides for 6-8 week survival in association with a range of adverse
events.

I believe this paragraph speaks volumes, as a Veterinary Practitioner would think really hard and long before recommending an Animal stay on an Un-approved Treatment,
Likewise a Dog Owner must be able to visually see the benefits of MPl ( especially with Quality of life , happy Dog , comfortable Dog, Dog with appetite) to request that there companion stay on an Un-approved Treatment..

Appreciate the Quarterly but we can all agree Q's are for current SH....... to increase liquidity in the stock we require fresh demand to participate in Pharmausts Success.....

The Quarterly is out early so does leave plenty of Month left to inform the wider market,,, who do not read every Quarterly......NZT